Page last updated: 2024-08-23

zidovudine and Abnormality, Heart

zidovudine has been researched along with Abnormality, Heart in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blanche, S; Bonnet, D; Delmas, S; Dollfus, C; Faye, A; Khoshnood, B; Le Chenadec, J; Lelong, N; Mandelbrot, L; Sibiude, J; Tubiana, R; Warszawski, J1
Albano, JD; Koram, N; Napier, MD; Scheuerle, AE; Tilson, H; Vannappagari, V1

Trials

1 trial(s) available for zidovudine and Abnormality, Heart

ArticleYear
In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Jul-15, Volume: 61, Issue:2

    Topics: Adult; Anti-HIV Agents; Drug Combinations; Echocardiography; Female; Follow-Up Studies; France; Heart Defects, Congenital; Heart Septal Defects, Ventricular; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Male; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, First; Sex Factors; Uterus; Young Adult; Zidovudine

2015

Other Studies

1 other study(ies) available for zidovudine and Abnormality, Heart

ArticleYear
Prenatal exposure to zidovudine and risk for ventricular septal defects and congenital heart defects: data from the Antiretroviral Pregnancy Registry.
    European journal of obstetrics, gynecology, and reproductive biology, 2016, Volume: 197

    Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Argentina; Brazil; Case-Control Studies; Female; France; Gestational Age; Heart Defects, Congenital; Heart Septal Defects, Ventricular; HIV Infections; Humans; Live Birth; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; Prenatal Exposure Delayed Effects; Prevalence; Prospective Studies; Registries; Risk Factors; South Africa; Uganda; United Kingdom; United States; Young Adult; Zidovudine

2016